Sinotherapeutics Inc.

Sinotherapeutics was founded in August 2012. It is a specialty pharma focus on the R&D, registration, manufacture and commercialization of complex generic products as well as innovative formulation products (505B2). The company aims to achieve commercialize its product globally, and to provide cost-effective high-quality products to international markets. The company has launched its product in multiple markets around the world, including metabolic, oncoly and CNS products. The company has its headquarter and R&D center located in the high-tech park in Pudong Zhangjiang district, Shanghai, China. The R&D center is well setup for formulation preparations, GMP analytical labs, and GMP pilot plants.The company also has a wholly owned commercial oral solid dosage form manufacture facilities, and high-potency formulation suits, both are located in Haimen City Jiangsu Provice, and have been audited and qualified multipletimes by US FDA and Chinese NMPA. The company's business also involves a small scale of the R&D, production and sales of high-end nutraceutical, nutritional products and dietary supplements.